Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
End-Stage renal disease and 30-day mortality for adults with and without COVID-19 — Stephanie L. Harrison (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
End-Stage renal disease and 30-day mortality for adults with and without COVID-19
Shared by
Professor Gregory Lip
University of Liverpool
End-Stage renal disease and 30-day mortality for adults with and without COVID-19
Article
2020
en
Authors
+3 more
SH
Stephanie L. Harrison
BB
Benjamin J. R. Buckley
EF
Elnara Fazio‐Eynullayeva
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2020
Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19
Stephanie L. Harrison
,
Elnara Fazio‐Eynullayeva
,
Deirdre A. Lane
,
Paula Underhill
,
Professor Gregory Lip
Article
2021
Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
Stephanie L. Harrison
,
Benjamin J. R. Buckley
,
Deirdre A. Lane
,
Paula Underhill
,
Professor Gregory Lip
Article
2009
Low Mortality and Key Aspects of Delivery of Care for End-Stage Renal Disease in Italy
Alexander Lauder
,
Arrigo Schieppati
,
Ferruccio Conte
,
Giuseppe Remuzzi
,
Daniel Batlle
Article
2010
Homocysteine Lowering in End-Stage Renal Disease
Lawrence de Koning
,
Frank B Hu
Article
2001
ACE Inhibitors to Prevent End-Stage Renal Disease
Piero Ruggenenti
,
Annalisa Perna
,
Giuseppe Remuzzi
Discussion(0)
No comments yet. Be the first to comment.